Table 2.
Univariate analysis for one-year mortality
| Variable | RR [95%CI] | p value |
|---|---|---|
| Age | 1.34 [1.01–1.68]a | 0.03 |
| Female | 1.10 [0.94–1.28] | 0.20 |
| Diabetes mellitus | 1.90 [0.90–4.02] | 0.10 |
| CCI | 1.32 [1.02–1.71] | 0.04 |
| PS 3–4 vs. 0–2 | 2.90 [1.55–5.45] | < 0.001 |
| PR3 vs. MPO | 0.75 [0.31–1.78] | 0.50 |
| Peak SCr | 1.13 [1.02–1.24]b | 0.01 |
| Dialysis | 2.40 [1.26–4.55] | 0.007 |
| Serum albumin | 0.94 [0.89–0.99] | 0.02 |
| Haemoglobin | 0.67 [0.52–0.86] | 0.002 |
| Leukocyte | 0.98 [0.89–1.07] | 0.62 |
| CRP | 0.99 [0.95–1.04] | 0.79 |
| BVAS | 1.04 [1.00–1.09] | 0.05 |
| FFS | 3.48 [2.10–5.79] | < 0.001 |
| CYC | 0.50 [0.22–1.12] | 0.09 |
| MP pulses | 0.83 [0.32–2.16] | 0.70 |
| PLEX | 1.66 [0.75–3.66] | 0.21 |
| Co-trimoxazole | 0.40 [0.20–0.84] | 0.02 |
| Infection at M1 | 3.47 [1.84–6.54] | < 0.001 |
| Leukopenia at M1 | 2.05 [0.76–5.56] | 0.15 |
RR relative risk, CI confidence interval, CCI Charlson Comorbidity Index, PS Performance Status, PR3 proteinase 3, MPO myeloperoxidase, SCr serum creatinine, CRP C-reactive protein, FFS Five-Factor Score, CYC cyclophosphamide, MP methylprednisolone, PLEX plasma exchange
aper 5 years
bper 100 μmol/l